MedPath

Injectable 2% Hyaluronic acid vs i-PRF for reconstruction of lost interdental papilla.

Not yet recruiting
Conditions
Lost interdental papilla
Other periodontal diseases, (2) ICD-10 Condition: K055||Other periodontal diseases,
Registration Number
CTRI/2023/07/055307
Lead Sponsor
Mohammed Ashif
Brief Summary

The interdental papilla is the gingival area that occupies the interproximal zone below the contact point between two adjacent teeth. In addition to having a positive effect on smile aesthetics, interdental papillae are important in preventing food impaction between teeth and contribute to improved phonetics.A deficient interdental papilla is known as the black triangle which can result from several factors, e.g. the age of the subject, the shape/size of teeth, the length of the proximal contact point, and the interproximal gingival thickness.

 Different treatment options are often proposed to close an open gingival embrasure, such as orthodontics or restorative, surgical and prosthetic care. However these methods are known to be invasive and unpredictable. Therefore minimally invasive techniques like 2% HA and i-PRF has been found to be effective and also most frequently used for the reconstruction of the lost interdental papilla.

As the HA and the i-PRF share similar properties in terms of promoting periodontal regeneration, collagen synthesis, and wound healing[7]. This study aimed to evaluate and compare the effectiveness of 2% injectable hyaluronic acid and i-PRF in the reconstruction of lost interdental papilla.

This study will include 14 systemically healthy participants, who meet the selection criteria ,reporting to the Department of Periodontology. Ethical clearance will be obtained and all the participants will b e subjected to oral prophylaxis before the study begins. The participants will be randomly allotted into one of the two study groups.

â–ª Group 1: For injectable 2% HA treatment protocol.

â–ª Group 2: For i-PRF protocol.

Clinical parameters such as (contact point to papillary tip [CP-PT] will be recorded using UNC 15 probe and standardized photographs taken for ImageJ software analysis) will be recorded at baseline, at the end of 1st and 3rd month , using these parameters the papillary fill will be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Systemically healthy participants.
  • 2.Class I or class II papilla according to Nordland and Tarnow’s Classification system for loss of papillary height.
  • 3.Loe and Silness gingival index less than or equal to 1.
Exclusion Criteria
  • Participants using any form of tobacco.
  • Pregnant or lactating females.
  • Participants who are already on anti-inflammatory or anti-bacterial drugs.
  • Participants using a drug which has influence in gingival growth.
  • Participants with midline diastema / loss of proximal contact.
  • Participants with untreated maxillary anterior caries, prosthesis and orthodontic appliances.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the amount of papillary fill in the maxillary anterior region in the following groups of participants at the end of 3rd month,Baseline, at the end of 1 month and at the end of 3rd month.
Group 1 with 2% Hyaluronic AcidBaseline, at the end of 1 month and at the end of 3rd month.
Group 2 with i-PRF.Baseline, at the end of 1 month and at the end of 3rd month.
Secondary Outcome Measures
NameTimeMethod
To evaluate the effectiveness of injectable platelet-rich fibrin (i-PRF) in the reconstruction of lost interdental papilla.At baseline, end of 1st and 3rd month
To compare the effectiveness of 2% HA and i-PRF in the reconstruction of lost interdental papilla.At baseline, endo of 1st and 3rd month

Trial Locations

Locations (1)

Yenepoya Dental college and hospital, Yenepoya University,

🇮🇳

Kannada, KARNATAKA, India

Yenepoya Dental college and hospital, Yenepoya University,
🇮🇳Kannada, KARNATAKA, India
Mohammed Ashif
Principal investigator
9846580917
23426@yenepoya.edu.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.